[go: up one dir, main page]

MX2019006768A - Peptidos antimicrobianos. - Google Patents

Peptidos antimicrobianos.

Info

Publication number
MX2019006768A
MX2019006768A MX2019006768A MX2019006768A MX2019006768A MX 2019006768 A MX2019006768 A MX 2019006768A MX 2019006768 A MX2019006768 A MX 2019006768A MX 2019006768 A MX2019006768 A MX 2019006768A MX 2019006768 A MX2019006768 A MX 2019006768A
Authority
MX
Mexico
Prior art keywords
antimicrobial peptides
formula
compounds
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
MX2019006768A
Other languages
English (en)
Inventor
Henninot Antoine
William Carney Daniel
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of MX2019006768A publication Critical patent/MX2019006768A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)

Abstract

Esta descripción se refiere a compuestos de la fórmula (I) o una sal farmacéuticamente aceptable de los mismos: Fórmula (I), en la cual n, R1, R1', R2, R3, R4, R4' y R5-R14 se definen en la especificación. Los compuestos de la fórmula (I) se pueden usar para tratar una infección bacteriana.
MX2019006768A 2016-12-13 2017-12-13 Peptidos antimicrobianos. MX2019006768A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662433567P 2016-12-13 2016-12-13
PCT/EP2017/082697 WO2018109042A2 (en) 2016-12-13 2017-12-13 Antimicrobial peptides

Publications (1)

Publication Number Publication Date
MX2019006768A true MX2019006768A (es) 2019-08-01

Family

ID=60788591

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019006768A MX2019006768A (es) 2016-12-13 2017-12-13 Peptidos antimicrobianos.

Country Status (13)

Country Link
US (1) US20200216493A1 (es)
EP (1) EP3554528A2 (es)
JP (1) JP2020500943A (es)
KR (1) KR20190093600A (es)
CN (1) CN110072539A (es)
AR (1) AR110514A1 (es)
AU (1) AU2017375034A1 (es)
BR (1) BR112019011010A2 (es)
CA (1) CA3047043A1 (es)
MX (1) MX2019006768A (es)
RU (1) RU2019120181A (es)
TW (1) TW201827415A (es)
WO (1) WO2018109042A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017181179A1 (en) * 2016-04-15 2017-10-19 The Regents Of The University Of California Antimicrobial compositions
JP2020510683A (ja) * 2017-03-09 2020-04-09 ユニバーシティ オブ リンカーン 新規抗菌製剤
EP3735415A4 (en) * 2018-01-03 2022-04-27 Versitech Limited NOVEL ANTIBIOTICS AND METHODS OF USING THE SAME
US12435108B2 (en) 2019-07-24 2025-10-07 Sunshine Lake Pharma Co., Ltd. Teixobactin analogue and use thereof
PL441789A1 (pl) * 2022-07-19 2024-01-22 Uniwersytet Warszawski Lipooligomoczniki, kompozycja farmaceutyczna, oraz lipooligomoczniki do zastosowania jako lek
GB202308886D0 (en) * 2023-06-14 2023-07-26 Univ Liverpool Anti-biofilm treatments

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50160492A (es) * 1974-06-22 1975-12-25
GB9724859D0 (en) * 1997-11-26 1998-01-21 Univ Nottingham Compounds and their use as antibacterial agents
EP1090034A2 (en) * 1998-06-24 2001-04-11 The Rockefeller University Novel staphylococcus peptides for bacterial interference
EP2381953A4 (en) * 2009-01-06 2016-06-29 C3 Jian Inc TARGETED ANTIMICROBIAL ELEMENTS
TW202012427A (zh) * 2012-12-03 2020-04-01 美商諾維生物製藥有限公司 新穎縮肽及其用途
WO2014113792A1 (en) * 2013-01-19 2014-07-24 New York University Hydrogen-bond surrogate peptides and peptidomimetics for p53 reactivation
WO2017181179A1 (en) * 2016-04-15 2017-10-19 The Regents Of The University Of California Antimicrobial compositions
CN106632604B (zh) * 2016-12-22 2021-03-19 深圳先进技术研究院 一种Teixobactin类似物及其制备方法和应用
CN107266531B (zh) * 2017-07-28 2020-04-07 北京大学深圳研究生院 Teixobactin及其制备方法

Also Published As

Publication number Publication date
RU2019120181A (ru) 2021-01-18
CA3047043A1 (en) 2018-06-21
KR20190093600A (ko) 2019-08-09
JP2020500943A (ja) 2020-01-16
CN110072539A (zh) 2019-07-30
WO2018109042A3 (en) 2018-07-26
WO2018109042A2 (en) 2018-06-21
EP3554528A2 (en) 2019-10-23
US20200216493A1 (en) 2020-07-09
AR110514A1 (es) 2019-04-03
AU2017375034A1 (en) 2019-06-13
TW201827415A (zh) 2018-08-01
BR112019011010A2 (pt) 2019-10-08

Similar Documents

Publication Publication Date Title
MX2022012317A (es) Oxisteroles y metodos de uso de los mismos.
MX2019006768A (es) Peptidos antimicrobianos.
MX2022005290A (es) Compuestos heterociclicos como inmunomoduladores.
PH12018501084B1 (en) Heterocyclic compounds as immunomodulators
GEP20186892B (en) 2-amino-3, 5, 5-trifluoro-3, 4, 5, 6-tetrahydropyridines as bace1 inhibitors for treatment of alzheimer's disease
NZ733174A (en) Quinazoline derivatives used to treat hiv
MX2017007814A (es) Compuesto de carbamoilpiridona policiclicos y su uso farmaceutico.
NZ733125A (en) Isoquinoline compounds for the treatment of hiv
AU2018253590A1 (en) Imidazopyridazine compounds
MX2017012393A (es) Compuestos de carbamoilpiridona policiclicos y su uso farmaceutico.
GEP20156370B (en) Fluoro-pyridinone derivatives useful as antibacterial agents
WO2015110969A3 (en) Nitrogen containing compounds and their use as antibacterial agents
MY209256A (en) Compounds affecting pigment production and use thereof for treatment of bacterial diseases
BR112017026061A2 (pt) composto, uso de um composto, e, método de tratamento de uma infecção viral
WO2016004513A8 (en) Anti-bacterial pyruvate kinase modulator compounds, compositions, uses and methods
PH12019502509A1 (en) Compounds and methods for treating bacterial infections
GEP20207190B (en) Methods for treatment and prophylaxis of hiv and aids
MX2020000576A (es) Compuestos quimicos.
MX2019011908A (es) Macrociclos de peptidos anti-bacterianos y uso de los mismos.
EP4272832A3 (en) Antimicrobial compounds, compositions, and uses thereof
PH12018500358A1 (en) Compounds for use in an antibacterial applications
MY194711A (en) Novel annelated phenoxyacetamides
WO2019040105A3 (en) COMPOUNDS, SALTS THEREOF AND METHODS FOR THE TREATMENT OF DISEASES
MX374568B (es) Formas sólidas que comprenden (1e, 4e)-2-amino-n,n-dipropil-8-(4-(pirrolidina-1-carbonil)fenil)-3h-benzo[b]azepina-4-carboxamida, composiciones de las mismas y usos de las mismas.
WO2015130547A8 (en) Bis-cyclic guanidine compound compositions, methods of use and treatment thereof